Medical supply chains are fragile in the best of times and COVID-19 will test their strength
- Written by Emily Tucker, Ph.D. Candidate in Industrial and Operations Engineering, University of Michigan
The pipeline of pharmaceuticals is easily disrupted.Gumpanat/iStock via Getty Images Plus
The COVID-19 pandemic has brought medical supply chains into the spotlight. There has been a national shortage of testing kits, and at least one drug is already unavailable because of the outbreak, though it hasn’t been publicly named.